Business Insider
My Markets Watchlist
Markets Stocks

DAIICHI SANKYO CO LTDShs Stock , DSKYF

3,454.00 JPY +2.00 +0.06%
02:30:00 AM TOKIO
News Analyst Data Analyst Opinions Insider Activity Dividend Calendar


DAIICHI SANKYO Stock Snapshot

44.12 B
Market Cap in USD
1.85 B
Number of Shares
1.85 B
Total Number of Shares
60.00
Dividend in JPY
1.71
Dividend Yield
22.51
P/E Ratio
87.10
Free Float in %
155.96
EPS in JPY
869.69
Book Value per Share in JPY
28.38
Cash Flow per Share in JPY

DAIICHI SANKYO Analyst Opinions

  • All
  • Buy
  • Hold
  • Sell
Date Analyst Rating Price

DAIICHI SANKYO Estimates* in JPY

  2026 2027 2028 2029 2030
Revenue 2,048,289 2,318,537 2,573,597 2,814,103 2,971,636
Dividend 77.28 89.12 98.68 117.55 117.50
Dividend Yield (in %) 2.24 % 2.58 % 2.86 % 3.41 % 3.40 %
EPS 163.83 203.65 242.74 285.65 296.47
P/E Ratio 21.07 16.95 14.22 12.08 11.64
EBIT 358,447 455,256 537,685 583,381 653,050
EBITDA 434,784 517,248 614,257 703,279 750,800
Net Profit 303,119 374,234 439,146 495,086 533,900
Net Profit Adjusted 325,321 373,500 472,062 532,537 -
Pre-Tax Profit 376,506 473,054 556,657 615,079 665,050
Pre-Tax Profit Reported 385,342 463,639 534,269 608,157 642,100
EPS (Non-GAAP) ex. SOE - - - - -
EPS (GAAP) - - 247.11 298.17 296.30
Gross Income 1,612,632 1,888,434 2,118,010 2,169,900 2,413,600
Cash Flow from Investing -52,381 -60,468 -37,223 -187,400 -187,400
Cash Flow from Operations 418,265 409,976 474,695 477,400 579,600
Cash Flow from Financing -320,084 -225,258 -221,544 -181,300 -208,400
Cash Flow per Share 232.09 226.20 254.33 356.96 -
Free Cash Flow 285,025 256,286 324,910 341,653 392,200
Free Cash Flow per Share 201.05 132.70 153.00 160.00 216.40
Book Value per Share 918.98 1,019.42 1,150.01 1,324.37 1,447.10
Net Debt -581,757 -621,139 -713,043 -950,281 -983,200
Research & Development Exp. 455,870 496,354 532,325 525,000 555,000
Capital Expenditure 141,977 143,675 142,472 193,470 187,400
Selling, General & Admin. Exp. 930,251 1,078,843 1,222,939 1,290,000 1,483,050
Shareholder’s Equity 1,717,224 1,984,851 2,323,505 2,314,600 2,622,900
Total Assets 3,607,976 3,938,836 4,409,993 5,257,100 4,498,100
  Previous Quarter
ending 03/31/25 		Current Quarter
ending 06/30/25 		Next Quarter
ending 09/30/25 		Current Year
ending 03/31/26 		Next Year
ending 03/31/27
Earnings Estimates
No. of Analysts - 5 5 13 13
Average Estimate - 35.068 JPY 38.798 JPY 163.830 JPY 203.649 JPY
Year Ago - 44.601 JPY 32.231 JPY 155.957 JPY -
Publish Date - - - - -
Revenue Estimates
No. of Analysts - 6 6 13 13
Average Estimate - 463,832 JPY 483,734 JPY 2,048,289 JPY 2,318,537 JPY
Year Ago - 436,175 JPY 446,552 JPY 1,886,256 JPY -
Publish Date - - - - -
* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet

Income Statements in Mio. JPY

2025 2024 2023 2022 2021 2020 2019
Sales 1,886,256.00 1,601,688.00 1,278,478.00 1,044,892.00 962,516.00 981,793.00 929,717.00
Change of sales in % 17.77 25.28 22.36 8.56 -1.96 5.60 -3.17
Gross profit on sales 1,470,459.00 1,181,795.00 914,953.00 682,090.00 624,227.00 638,587.00 565,112.00
Gross profit on sales change in % 24.43 29.16 34.14 9.27 -2.25 13.00 -7.99
Operating income 303,294.00 186,018.00 121,817.00 82,462.00 80,179.00 118,028.00 90,461.00
Operating income change in % 63.05 52.70 47.73 2.85 -32.07 30.47 -19.47
Income before tax 354,174.00 237,050.00 126,873.00 73,387.00 73,956.00 141,164.00 85,831.00
Income before tax change in % 49.41 86.84 72.88 -0.77 -47.61 64.47 5.94
Income after tax 295,756.00 200,731.00 109,188.00 66,972.00 75,957.00 129,074.00 93,410.00
Income after tax change in % 47.34 83.84 63.04 -11.83 -41.15 38.18 54.96

Balance Sheet in Mio. JPY

2025 2024 2023 2022 2021 2020 2019
Total liabilities 1,832,698.00 1,772,527.00 1,063,031.00 870,526.00 813,121.00 799,339.00 838,343.00
Long-term liabilities per share 577.86 542.23 274.75 244.99 236.65 226.56 233.48
Equity 1,623,416.00 1,688,602.00 1,445,854.00 1,350,872.00 1,272,053.00 1,306,273.00 1,249,704.00
Equity change in % -3.84 16.76 7.03 6.20 -2.59 4.49 10.30
Balance sheet total 3,456,119.00 3,461,129.00 2,508,885.00 2,221,398.00 2,085,174.00 2,105,612.00 2,088,047.00
Balance sheet total change in % -0.14 37.95 12.94 6.53 -0.97 0.84 10.03

Key Data in JPY

2025 2024 2023 2022 2021 2020 2019
Sales per share 994.08 834.80 666.36 544.64 495.64 504.05 477.34
P/E ratio (year end quote, basic EPS) 22.51 45.63 84.66 76.70 82.34 37.32 35.37
P/E ratio (year end quote, diluted EPS) 22.53 45.66 84.73 76.77 82.45 37.39 35.45
Dividend yield in % 1.71 1.05 0.62 1.01 0.84 0.94 1.37
Equity ratio in % 46.97 48.79 57.63 60.81 61.00 62.04 59.85
Debt ratio in % 53.03 51.21 42.37 39.19 39.00 37.96 40.15

DAIICHI SANKYO Dividend Calendar

Date Name Dividend *yield Currency
2025 DAIICHI SANKYO CO LTDShs 60.00 1.71 JPY
2024 DAIICHI SANKYO CO LTDShs 50.00 1.05 JPY
2023 DAIICHI SANKYO CO LTDShs 30.00 0.62 JPY
2022 DAIICHI SANKYO CO LTDShs 27.00 1.01 JPY
2021 DAIICHI SANKYO CO LTDShs 27.00 0.84 JPY
2020 DAIICHI SANKYO CO LTDShs 23.33 0.94 JPY
2019 DAIICHI SANKYO CO LTDShs 23.33 1.37 JPY
2018 DAIICHI SANKYO CO LTDShs 23.33 1.99 JPY
2017 DAIICHI SANKYO CO LTDShs 23.33 2.79 JPY
2016 DAIICHI SANKYO CO LTDShs 23.33 2.80 JPY
2015 DAIICHI SANKYO CO LTDShs 20.00 3.15 JPY
2014 DAIICHI SANKYO CO LTDShs 20.00 3.45 JPY
2013 DAIICHI SANKYO CO LTDShs 20.00 3.31 JPY
2012 DAIICHI SANKYO CO LTDShs 20.00 3.98 JPY
2011 DAIICHI SANKYO CO LTDShs 20.00 3.74 JPY
2010 DAIICHI SANKYO CO LTDShs 20.00 3.43 JPY
2009 DAIICHI SANKYO CO LTDShs 80.00 4.85 JPY
*Yield of the Respective Date

DAIICHI SANKYO Calendar

Event Estimate Info Date
Earnings Report 44.600 JPY Q1 2025 Earnings Release 07/30/2025
Earnings Report 32.230 JPY Q2 2025 Earnings Release 10/29/2025
Earnings Report 32.820 JPY Q3 2025 Earnings Release 01/30/2026
Earnings Report 46.310 JPY Q4 2025 Earnings Release 04/23/2026

DAIICHI SANKYO Past Events

Event Actual EPS Info Date
Earnings Report 19.380 JPY Q4 2024 Earnings Release 04/25/2025
Earnings Report 34.710 JPY Q3 2024 Earnings Release 01/31/2025
Earnings Report 20.860 JPY Q2 2024 Earnings Release 10/31/2024
Earnings Report 29.740 JPY Q1 2024 Earnings Release 07/31/2024
Earnings Report 11.730 JPY Q4 2023 Earnings Release 04/25/2024
Earnings Report 14.810 JPY Q3 2023 Earnings Release 01/31/2024
Earnings Report 20.580 JPY Q2 2023 Earnings Release 10/31/2023
Earnings Report 9.840 JPY Q1 2023 Earnings Release 07/31/2023
Earnings Report -14.270 JPY Q4 2022 Earnings Release 04/27/2023
Earnings Report 16.620 JPY Q3 2022 Earnings Release 01/31/2023
Earnings Report 14.220 JPY Q2 2022 Earnings Release 10/31/2022
Earnings Report 18.380 JPY Q1 2022 Earnings Release 07/29/2022
Earnings Report 0.080 JPY Q4 2021 Earnings Release 04/27/2022
Earnings Report 12.430 JPY Q3 2021 Earnings Release 01/31/2022

DAIICHI SANKYO Profile

Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.

Moody’s Daily Credit Risk Score

Risk
  • Low
  • Medium
  • High
3
Moody’s Daily Credit Risk Score is a 1-10 score of a company’s credit risk, based on an analysis of the firm’s balance sheet and inputs from the stock market. The score provides a forward-looking, one-year measure of credit risk, allowing investors to make better decisions and streamline their work ow. Updated daily, it takes into account day-to-day movements in market value compared to a company’s liability structure.

DAIICHI SANKYO Management

Name Job
Kenji Sato Auditor
Miyuki Arai Auditor
James Felix Chief Digital Transformation Officer
Akira Ogawa Chief Financial Officer & Head-Global Planning
Naoki Shimizu Chief Quality Officer
Takashi Fukuoka Director
Takashi Matsumoto Director & Chief Human Resources Officer
Sunao Manabe Executive Chairman
Naoto Tsukaguchi General Counsel, Head-Global Legal & IP
Hiroto Kashiwasawa General Manager-Technology
Matt Allegrucci Head-Global Compliance & Risk Management
Terumichi Yokoyama Head-Global Internal Audit
Akio Sakurai Head-Sales & Marketing Division
Kazuaki Kama Independent Outside Director
Sawako Nohara Independent Outside Director
Takaaki Nishii Independent Outside Director
Yasuhiro Komatsu Independent Outside Director
Yo Honma Independent Outside Director
Tomohiro Kodama Manager-Accounting & Finance
Tetsuya Iwabuchi Manager-Business Development
Hiroyuki Okuzawa President, CEO & Representative Director
Shoji Hirashima Representative Director
Satoshi Ogawa Secretary
Ueno Shizuko Senior Exceutive Officer & Head-Medical Affaris
Nobuo Murakami Senior Executive Officer & Manger-Corporate
Yuki Abe VP-Research & Development Division